NO990909D0 - Farmas°ytisk sammensetning inneholdende lornoxicam og et dinatriumsalt av EDTA - Google Patents
Farmas°ytisk sammensetning inneholdende lornoxicam og et dinatriumsalt av EDTAInfo
- Publication number
- NO990909D0 NO990909D0 NO990909A NO990909A NO990909D0 NO 990909 D0 NO990909 D0 NO 990909D0 NO 990909 A NO990909 A NO 990909A NO 990909 A NO990909 A NO 990909A NO 990909 D0 NO990909 D0 NO 990909D0
- Authority
- NO
- Norway
- Prior art keywords
- edta
- composition containing
- disodium salt
- surface composition
- lornoxicam
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Dermatology (AREA)
- Ophthalmology & Optometry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Rheumatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AT0156496A ATA156496A (de) | 1996-09-03 | 1996-09-03 | Pharmazeutische zusammensetzung |
PCT/EP1997/004742 WO1998009654A1 (de) | 1996-09-03 | 1997-09-01 | Pharmazeutische zusammensetzung enthaltend lornoxicam und ein dinatriumsalz der edta |
Publications (3)
Publication Number | Publication Date |
---|---|
NO990909D0 true NO990909D0 (no) | 1999-02-25 |
NO990909L NO990909L (no) | 1999-02-25 |
NO326350B1 NO326350B1 (no) | 2008-11-17 |
Family
ID=3516134
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO19990909A NO326350B1 (no) | 1996-09-03 | 1999-02-25 | Farmasoytisk sammensetning inneholdende lornoxicam og et dinatriumsalt av EDTA |
Country Status (12)
Country | Link |
---|---|
EP (1) | EP0934079B1 (no) |
JP (1) | JP4122062B2 (no) |
CN (1) | CN1108822C (no) |
AT (2) | ATA156496A (no) |
AU (1) | AU4552597A (no) |
CA (1) | CA2264626C (no) |
DE (1) | DE59706450D1 (no) |
DK (1) | DK0934079T3 (no) |
ES (1) | ES2172002T3 (no) |
NO (1) | NO326350B1 (no) |
PT (1) | PT934079E (no) |
WO (1) | WO1998009654A1 (no) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2001172183A (ja) * | 1999-12-21 | 2001-06-26 | Wakamoto Pharmaceut Co Ltd | 眼科用医薬組成物 |
DE10030345A1 (de) * | 2000-06-20 | 2002-01-10 | Boehringer Ingelheim Vetmed | Hochkonzentrierte stabile Meloxicamlösungen |
US20020035107A1 (en) | 2000-06-20 | 2002-03-21 | Stefan Henke | Highly concentrated stable meloxicam solutions |
DE10161077A1 (de) * | 2001-12-12 | 2003-06-18 | Boehringer Ingelheim Vetmed | Hochkonzentrierte stabile Meloxicamlösungen zur nadellosen Injektion |
US8992980B2 (en) | 2002-10-25 | 2015-03-31 | Boehringer Ingelheim Vetmedica Gmbh | Water-soluble meloxicam granules |
JO2735B1 (en) | 2003-01-30 | 2013-09-15 | هيلسين هيلث كير أس ايه. | Liquid pharmaceutical formations of balloonosterone |
EP1568369A1 (en) | 2004-02-23 | 2005-08-31 | Boehringer Ingelheim Vetmedica Gmbh | Use of meloxicam for the treatment of respiratory diseases in pigs |
IN2012DN03157A (no) | 2009-10-12 | 2015-09-18 | Boehringer Ingelheim Vetmed | |
WO2011107150A1 (en) | 2010-03-03 | 2011-09-09 | Boehringer Ingelheim Vetmedica Gmbh | Use of meloxicam for the long-term treatment of musculoskeletal disorders in cats |
US9795568B2 (en) | 2010-05-05 | 2017-10-24 | Boehringer Ingelheim Vetmedica Gmbh | Low concentration meloxicam tablets |
WO2012127496A1 (en) | 2011-03-01 | 2012-09-27 | Cadila Healthcare Limited | Stable pharmaceutical compositions of lornoxicam or salts thereof |
CN106727364B (zh) * | 2016-12-02 | 2020-01-24 | 苏州天马医药集团天吉生物制药有限公司 | 一种注射用氯诺昔康的冻干工艺 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT1203703B (it) * | 1983-05-23 | 1989-02-15 | Bruschettin Srl | Composizione farmaceutica a carattere di collirio ad azione antiinfiammatoria,e procedimento per la sua preparazione |
US5362758A (en) * | 1992-09-18 | 1994-11-08 | Pfizer Inc. | Ophthalmic piroxicam solution |
WO1996041646A2 (en) * | 1995-06-13 | 1996-12-27 | Dyer, Alison, Margaret | Pharmaceutical compositions containing lornoxicam and cyclodextrin |
-
1996
- 1996-09-03 AT AT0156496A patent/ATA156496A/de not_active Application Discontinuation
-
1997
- 1997-09-01 ES ES97943820T patent/ES2172002T3/es not_active Expired - Lifetime
- 1997-09-01 PT PT97943820T patent/PT934079E/pt unknown
- 1997-09-01 JP JP51222198A patent/JP4122062B2/ja not_active Expired - Lifetime
- 1997-09-01 CN CN97197619A patent/CN1108822C/zh not_active Expired - Lifetime
- 1997-09-01 DE DE59706450T patent/DE59706450D1/de not_active Expired - Lifetime
- 1997-09-01 AT AT97943820T patent/ATE213420T1/de active
- 1997-09-01 DK DK97943820T patent/DK0934079T3/da active
- 1997-09-01 EP EP97943820A patent/EP0934079B1/de not_active Expired - Lifetime
- 1997-09-01 AU AU45525/97A patent/AU4552597A/en not_active Abandoned
- 1997-09-01 WO PCT/EP1997/004742 patent/WO1998009654A1/de active IP Right Grant
- 1997-09-01 CA CA002264626A patent/CA2264626C/en not_active Expired - Lifetime
-
1999
- 1999-02-25 NO NO19990909A patent/NO326350B1/no not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
CN1228710A (zh) | 1999-09-15 |
CA2264626C (en) | 2009-03-24 |
JP4122062B2 (ja) | 2008-07-23 |
CN1108822C (zh) | 2003-05-21 |
EP0934079B1 (de) | 2002-02-20 |
EP0934079A1 (de) | 1999-08-11 |
NO326350B1 (no) | 2008-11-17 |
AU4552597A (en) | 1998-03-26 |
CA2264626A1 (en) | 1998-03-12 |
JP2000517331A (ja) | 2000-12-26 |
NO990909L (no) | 1999-02-25 |
WO1998009654A1 (de) | 1998-03-12 |
PT934079E (pt) | 2002-06-28 |
ES2172002T3 (es) | 2002-09-16 |
ATE213420T1 (de) | 2002-03-15 |
DK0934079T3 (da) | 2002-04-02 |
DE59706450D1 (de) | 2002-03-28 |
ATA156496A (de) | 1997-10-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EE9800187A (et) | Trombiini inhibiitorite eelravimid | |
NO965327D0 (no) | Sporbare brönnsementsammensetninger og metoder | |
LV12102A (lv) | Rotamazes funkciju inhibitori | |
BR9607791A (pt) | Formulação oral de 2-metil-tieno-benzodiazepina | |
DE69412842T2 (de) | Endodontisches instrument vorbestimmter flexibilität | |
DK0850004T3 (da) | Tandbørste og fremgangsmåde til fremstilling af en sådan | |
PL322904A1 (en) | Sulphonamidic inhibitors of aspartil protease containing oxidated heterocyclic group | |
NO974495D0 (no) | Forbindelse og sammensetninger for levering av aktive midler | |
PL322877A1 (en) | Sulphonamidic inhibitors of aspartil hiv protease containing thf | |
NO954056L (no) | Kombinasjon av laser tracker og kamerabasert koordinatmåling | |
NO990909D0 (no) | Farmas°ytisk sammensetning inneholdende lornoxicam og et dinatriumsalt av EDTA | |
MX9205725A (es) | Formulaciones generantes de gas no azidico | |
DK42093D0 (da) | Administrationsmetode | |
DK516487A (da) | Laegemiddel indholdende en kombination af angiotensin-converting-enzyme-inhibitorer og calciumantagonister | |
IS1821B (is) | Samsetning 5-HT upptöku-hemils og valkvæðs 5-HT 1A -mótlyfs | |
HUP9904065A2 (hu) | Olanzapint tartalmazó bevonatos gyógyszerkészítmények | |
BR9407743A (pt) | Composiçao oral de peróxido de cálcio-bicarbonato | |
NO20054619D0 (no) | Sammensetninger og fremgangsmater for behandling av underjordiske formasjoner | |
ID22716A (id) | Peneboran benda benda padat lembut yang diberi bentuk | |
IT1276799B1 (it) | Formulazioni di f-silicone | |
NO924528L (no) | Derivater av humant gallesalt-stimulert lipase og farmasoeytiske sammensetninger som inneholder disse | |
FI973500A (fi) | 3-pyrrolidylideeni-2-oni-kefalosporiinien johdannaiset | |
DE69631339D1 (de) | Verwaltung kryptographischer schlüssel | |
KR960031694U (ko) | 콘크리트로 만든 폼타이용 콘-넛트 | |
NO953272L (no) | Kombinasjoner av retrovirale inhibitorer |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
CHAD | Change of the owner's name or address (par. 44 patent law, par. patentforskriften) |
Owner name: TAKEDA PHARMA A/S, DK |
|
MK1K | Patent expired |